CyclophosphamideRemission InductionGlucocorticoidsRemission, SpontaneousCytarabineDexamethasoneVincristineAsparaginaseAntineoplastic Combined Chemotherapy ProtocolsDaunorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaMethotrexatePrednisoneLeukemia, Myeloid, Acute6-MercaptopurineDoxorubicinTreatment OutcomePrednisoloneThioguanineIdarubicinDisease-Free SurvivalLeukemia, MyeloidEtoposideLeukemia, LymphoidDrug Administration ScheduleRecurrenceReceptors, GlucocorticoidCombined Modality TherapyPrognosisAcute DiseaseEnzyme InductionBone Marrow TransplantationTime FactorsBone MarrowPhosphoramide MustardsAntineoplastic Agents, AlkylatingDrug Therapy, CombinationLeukemiaNeoplasm, ResidualSurvival AnalysisImmunosuppressive AgentsAntineoplastic AgentsLeukemia, Promyelocytic, AcuteLeukocyte CountSurvival RateMifepristoneFollow-Up StudiesHematopoietic Stem Cell TransplantationPulse Therapy, DrugBlast CrisisHydrocortisoneMethylprednisoloneDose-Response Relationship, DrugTransplantation, HomologousClinical Trials as TopicCorticosteroneAntibodies, MonoclonalPlatelet CountAdrenalectomyAntibodies, Monoclonal, Murine-DerivedRNA, MessengerTransplantation, AutologousBusulfanRetrospective StudiesAnti-Inflammatory AgentsLymphoma, Non-HodgkinEpirubicinProspective StudiesThiotepaDisseminated Intravascular CoagulationInjections, SpinalCells, CulturedBreast NeoplasmsVidarabineLeukopeniaGranulocyte Colony-Stimulating FactorFluorouracilGene Expression RegulationWhole-Body IrradiationWegener GranulomatosisCortisone11-beta-Hydroxysteroid Dehydrogenase Type 1AzathioprineTransplantation ConditioningMelphalan11-beta-Hydroxysteroid DehydrogenasesHormone AntagonistsCell LineMice, Inbred C57BLImmunosuppression11-beta-Hydroxysteroid Dehydrogenase Type 2Age FactorsNephrotic SyndromeCarmustineTranscription, GeneticCisplatinLupus NephritisBleomycinApoptosisChemotherapy, Adjuvant